Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
Doan, Tan N; Fox, Greg J; Meehan, Michael T; Scott, Nick; Ragonnet, Romain; Viney, Kerri; Trauer, James M; McBryde, Emma S
Journal of Antimicrobial Chemotherapy.
74(1):218-227, January 2019.
(Format: HTML, PDF)